Literature DB >> 27768276

Dnmt3b Methylates DNA by a Noncooperative Mechanism, and Its Activity Is Unaffected by Manipulations at the Predicted Dimer Interface.

Allison B Norvil1, Christopher J Petell1, Lama Alabdi1, Lanchen Wu1, Sandra Rossie1, Humaira Gowher1.   

Abstract

The catalytic domains of the de novo DNA methyltransferases Dnmt3a-C and Dnmt3b-C are highly homologous. However, their unique biochemical properties could potentially contribute to differences in the substrate preferences or biological functions of these enzymes. Dnmt3a-C forms tetramers through interactions at the dimer interface, which also promote multimerization on DNA and cooperativity. Similar to the case for processive enzymes, cooperativity allows Dnmt3a-C to methylate multiple sites on the same DNA molecule; however, it is unclear whether Dnmt3b-C methylates DNA by a cooperative or processive mechanism. The importance of the tetramer structure and cooperative mechanism is emphasized by the observation that the R882H mutation in the dimer interface of DNMT3A is highly prevalent in acute myeloid leukemia and leads to a substantial loss of its activity. Under conditions that distinguish between cooperativity and processivity, we show that in contrast to that of Dnmt3a-C, the activity of Dnmt3b-C is not cooperative and confirm the processivity of Dnmt3b-C and the full length Dnmt3b enzyme. Whereas the R878H mutation (mouse homologue of R882H) led to the loss of cooperativity of Dnmt3a-C, the activity and processivity of the analogous Dnmt3b-C R829H variant were comparable to those of the wild-type enzyme. Additionally, buffer acidification that attenuates the dimer interface interactions of Dnmt3a-C had no effect on Dnmt3b-C activity. Taken together, these results demonstrate an important mechanistic difference between Dnmt3b and Dnmt3a and suggest that interactions at the dimer interface may play a limited role in regulating Dnmt3b-C activity. These new insights have potential implications for the distinct biological roles of Dnmt3a and Dnmt3b.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27768276      PMCID: PMC5992102          DOI: 10.1021/acs.biochem.6b00964

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  46 in total

1.  The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.

Authors:  David A Russler-Germain; David H Spencer; Margaret A Young; Tamara L Lamprecht; Christopher A Miller; Robert Fulton; Matthew R Meyer; Petra Erdmann-Gilmore; R Reid Townsend; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

Review 2.  Structure and function of mammalian DNA methyltransferases.

Authors:  Renata Zofia Jurkowska; Tomasz Piotr Jurkowski; Albert Jeltsch
Journal:  Chembiochem       Date:  2010-11-29       Impact factor: 3.164

3.  Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases.

Authors:  Humaira Gowher; Albert Jeltsch
Journal:  J Biol Chem       Date:  2002-03-27       Impact factor: 5.157

4.  EcoRI methylase. Physical and catalytic properties of the homogeneous enzyme.

Authors:  R A Rubin; P Modrich
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

Review 5.  The role of mutations in epigenetic regulators in myeloid malignancies.

Authors:  Alan H Shih; Omar Abdel-Wahab; Jay P Patel; Ross L Levine
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

6.  Biotin-avidin microplate assay for the quantitative analysis of enzymatic methylation of DNA by DNA methyltransferases.

Authors:  M Roth; A Jeltsch
Journal:  Biol Chem       Date:  2000-03       Impact factor: 3.915

7.  DNMT3A mutations in acute myeloid leukemia.

Authors:  Timothy J Ley; Li Ding; Matthew J Walter; Michael D McLellan; Tamara Lamprecht; David E Larson; Cyriac Kandoth; Jacqueline E Payton; Jack Baty; John Welch; Christopher C Harris; Cheryl F Lichti; R Reid Townsend; Robert S Fulton; David J Dooling; Daniel C Koboldt; Heather Schmidt; Qunyuan Zhang; John R Osborne; Ling Lin; Michelle O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Vincent J Magrini; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Joshua J Conyers; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd Wylie; Jason Walker; Joelle Kalicki; Mark A Watson; Sharon Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Peter Westervelt; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Richard K Wilson
Journal:  N Engl J Med       Date:  2010-11-10       Impact factor: 91.245

Review 8.  Systematic evaluation of cancer risk associated with DNMT3B polymorphisms.

Authors:  Fujiao Duan; Shuli Cui; Chunhua Song; Liping Dai; Xia Zhao; Xiaoqin Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-11       Impact factor: 4.553

9.  Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation.

Authors:  Da Jia; Renata Z Jurkowska; Xing Zhang; Albert Jeltsch; Xiaodong Cheng
Journal:  Nature       Date:  2007-08-22       Impact factor: 49.962

10.  Mode of action of the Spiroplasma CpG methylase M.SssI.

Authors:  P Renbaum; A Razin
Journal:  FEBS Lett       Date:  1992-11-30       Impact factor: 4.124

View more
  10 in total

Review 1.  Mammalian DNA methyltransferases: new discoveries and open questions.

Authors:  Humaira Gowher; Albert Jeltsch
Journal:  Biochem Soc Trans       Date:  2018-08-28       Impact factor: 5.407

2.  The acute myeloid leukemia variant DNMT3A Arg882His is a DNMT3B-like enzyme.

Authors:  Allison B Norvil; Lama AlAbdi; Bigang Liu; Yu Han Tu; Nicole E Forstoffer; Amie R Michie; Taiping Chen; Humaira Gowher
Journal:  Nucleic Acids Res       Date:  2020-04-17       Impact factor: 16.971

Review 3.  The language of chromatin modification in human cancers.

Authors:  Shuai Zhao; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2021-05-17       Impact factor: 60.716

Review 4.  Effect of Disease-Associated Germline Mutations on Structure Function Relationship of DNA Methyltransferases.

Authors:  Allison B Norvil; Debapriya Saha; Mohd Saleem Dar; Humaira Gowher
Journal:  Genes (Basel)       Date:  2019-05-14       Impact factor: 4.096

Review 5.  Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy.

Authors:  Anna Rugowska; Alicja Starosta; Patryk Konieczny
Journal:  Clin Epigenetics       Date:  2021-01-19       Impact factor: 6.551

6.  Misregulation of the expression and activity of DNA methyltransferases in cancer.

Authors:  Isaiah K Mensah; Allison B Norvil; Lama AlAbdi; Sarah McGovern; Christopher J Petell; Ming He; Humaira Gowher
Journal:  NAR Cancer       Date:  2021-12-01

7.  Epigenetic alterations associated with dexamethasone sodium phosphate through DNMT and TET in RPE cells.

Authors:  Wenjie Liu; Sruthi Priya Mohan; Nareshkumar Ragavachetty Nagaraj; Shyam Sundar Jaganathan; Yi Wen; Sharada Ramasubramanyan; Joseph Irudayaraj
Journal:  Mol Vis       Date:  2021-11-20       Impact factor: 2.367

Review 8.  Alterations to DNMT3A in Hematologic Malignancies.

Authors:  Kartika Venugopal; Yang Feng; Daniil Shabashvili; Olga A Guryanova
Journal:  Cancer Res       Date:  2020-10-21       Impact factor: 13.312

9.  Structural insights into CpG-specific DNA methylation by human DNA methyltransferase 3B.

Authors:  Chien-Chu Lin; Yi-Ping Chen; Wei-Zen Yang; James C K Shen; Hanna S Yuan
Journal:  Nucleic Acids Res       Date:  2020-04-17       Impact factor: 16.971

Review 10.  DNMTs and Impact of CpG Content, Transcription Factors, Consensus Motifs, lncRNAs, and Histone Marks on DNA Methylation.

Authors:  Jaqueline Loaeza-Loaeza; Adriana S Beltran; Daniel Hernández-Sotelo
Journal:  Genes (Basel)       Date:  2020-11-12       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.